Bilateral functional worsening following voretigene neparvovec therapy
暂无分享，去创建一个
Ana Luísa Carvalho | J. Figueira | J. Murta | J. Marques | Teresa Mesquita | M. Alfaiate | Catarina Paiva | Emmanuel Rebelo Neves
[1] U. Christensen,et al. Inflammation after voretigene neparvovec administration in patients with RPE65-related retinal dystrophy. , 2022, Ophthalmology.
[2] Christina Y Weng,et al. Visual Acuity, Retinal Morphology, and Patients' Perceptions after Voretigene Neparvovec-rzyl for RPE65-Associated Retinal Disease. , 2021, Ophthalmology. Retina.
[3] Jesse D. Sengillo,et al. Perifoveal Chorioretinal Atrophy following Subretinal Voretigene Neparvovec-rzyl for RPE65-mediated Leber Congenital Amaurosis. , 2021, Ophthalmology. Retina.
[4] S. Russell,et al. Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 Years and 4 Years. , 2021, Ophthalmology.
[5] Seongjin Seo,et al. Differential requirement of NPHP1 for compartmentalized protein localization during photoreceptor outer segment development and maintenance , 2021, bioRxiv.